Glendon E. French III - Aug 19, 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
President and CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Stock symbol
LUNG
Transactions as of
Aug 19, 2021
Transactions value $
-$952,340
Form type
4
Date filed
8/23/2021, 06:31 PM
Previous filing
Jul 19, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$36.6K -1K -4.07% $36.59 23.6K Aug 19, 2021 See footnote F1, F2
transaction LUNG Common Stock Sale -$916K -25K -2.07% $36.63 1.18M Aug 19, 2021 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020.
F2 The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $37.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 Includes 57 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on August 13, 2021.